Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs Fluticasone Propionate in Pediatric Allergic Rhinitis
NCT04957927Phase 4Unknown
- Start
- Dec 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of montelukast in allergic rhinitis (AR) (2 arms). Primary endpoint: Improvement in Day and Night time nasal symptoms score of Allergic Rhinitis at 2 months. Status: unknown.
02
Drugs
montelukast
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT04957927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04957927.